- Home
- LUNR vs DAWN Comparison
LUNR vs DAWN Comparison
Compare LUNR & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNR
- DAWN
- Stock Information
- Founded
- LUNR 2013
- DAWN 2018
- Country
- LUNR United States
- DAWN United States
- Employees
- LUNR N/A
- DAWN N/A
- Industry
- LUNR Industrial Machinery/Components
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- LUNR Industrials
- DAWN Health Care
- Exchange
- LUNR Nasdaq
- DAWN Nasdaq
- Market Cap
- LUNR 1.7B
- DAWN 1.3B
- IPO Year
- LUNR N/A
- DAWN 2021
- Fundamental
- Price
- LUNR $21.89
- DAWN $12.59
- Analyst Decision
- LUNR Strong Buy
- DAWN Strong Buy
- Analyst Count
- LUNR 5
- DAWN 7
- Target Price
- LUNR $14.10
- DAWN $36.17
- AVG Volume (30 Days)
- LUNR 16.7M
- DAWN 894.5K
- Earning Date
- LUNR 11-14-2024
- DAWN 02-24-2025
- Dividend Yield
- LUNR N/A
- DAWN N/A
- EPS Growth
- LUNR N/A
- DAWN N/A
- EPS
- LUNR N/A
- DAWN N/A
- Revenue
- LUNR $203,899,000.00
- DAWN $101,953,000.00
- Revenue This Year
- LUNR $192.10
- DAWN N/A
- Revenue Next Year
- LUNR $60.58
- DAWN $36.10
- P/E Ratio
- LUNR N/A
- DAWN N/A
- Revenue Growth
- LUNR 134.51
- DAWN N/A
- 52 Week Low
- LUNR $2.10
- DAWN $11.94
- 52 Week High
- LUNR $22.12
- DAWN $18.07
- Technical
- Relative Strength Index (RSI)
- LUNR 75.08
- DAWN 39.39
- Support Level
- LUNR $17.27
- DAWN $12.40
- Resistance Level
- LUNR $19.62
- DAWN $13.30
- Average True Range (ATR)
- LUNR 2.11
- DAWN 0.48
- MACD
- LUNR 0.65
- DAWN 0.04
- Stochastic Oscillator
- LUNR 97.90
- DAWN 40.34
About LUNR Intuitive Machines Inc.
Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.